Literature DB >> 623664

Binding of adriamycin to sulphated mucopolysaccharides.

M Menozzi, F Arcamone.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1978        PMID： 623664     DOI： 10.1016/0006-291x(78)90678-2

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN： 0006-291X            Impact factor:   3.575


× No keyword cloud information.
  9 in total

Review 1.  Doxorubicin effects on contractile structures and molecules.

Authors:  R Colombo; A Milzani; A Necco; G Vailati
Journal:  Cytotechnology       Date:  1990-01       Impact factor: 2.058

2.  Changes in the electrochemical composition of cochlear fluids after intracisternal application of doxorubicin in the rat.

Authors:  I Sziklai; E Ferrary; A Loiseau; O Sterkers; C Amiel
Journal:  Eur Arch Otorhinolaryngol       Date:  1992       Impact factor: 2.503

Review 3.  Pharmacokinetic drug interactions of commonly used anticancer drugs.

Authors:  F M Balis
Journal:  Clin Pharmacokinet       Date:  1986 May-Jun       Impact factor: 6.447

4.  Characteristics and effect of antiinflammatory drugs on adriamycin-induced inflammation in the mouse paw.

Authors:  D M Siegel; S N Giri; R M Scheinholtz; L W Schwartz
Journal:  Inflammation       Date:  1980-06       Impact factor: 4.092

5.  Doxorubicin-heparin complex: reduction of cardiotoxicity of doxorubicin.

Authors:  Y Mizuno; T Hara; S Tachibana; K Uragoh; K Akazawa; K Ueda
Journal:  J Cancer Res Clin Oncol       Date:  1995       Impact factor: 4.553

6.  Doxorubicin binds in a cooperative manner to myocardial cells. Two binding sites.

Authors:  K Wassermann; E Steiness
Journal:  Cancer Chemother Pharmacol       Date:  1986       Impact factor: 3.333

7.  Comparative nuclear and cellular incorporation of daunorubicin, doxorubicin, carminomycin, marcellomycin, aclacinomycin A and AD 32 in daunorubicin-sensitive and -resistant Ehrlich ascites in vitro.

Authors:  S Seeber; H Loth; S T Crooke
Journal:  J Cancer Res Clin Oncol       Date:  1980       Impact factor: 4.553

8.  Non interference by heparin with the cytostatic effect of adriamycin: an in vitro study on a human promyelocytic leukaemia cell line.

Authors:  P Foa; E Cofrancesco; L Lombardi; M Colombi; E M Pogliani; E E Polli
Journal:  Br J Cancer       Date:  1983-11       Impact factor: 7.640

9.  Heparin does not modify plasma daunomycin disappearance in acute leukaemia patients.

Authors:  E Piazza; S Cortellazzo; L Ottolenghi; A Poggi; T Barbui; M B Donati
Journal:  Br J Cancer       Date:  1980-11       Impact factor: 7.640
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.